What is the current PRFN.SW stock price and intraday change?

PRFN.SW stock last traded at **CHF 0.036**, down **-8.12%** for the session. The intraday range was **CHF 0.0352** to **CHF 0.040** with volume of **2,937,350** shares.

What rating does Meyka AI give PRFN.SW stock?

Meyka AI rates PRFN.SW with a score of **59.75 out of 100**, grade **C+**, and a **HOLD** suggestion. The grade combines benchmark, sector, metrics and analyst signals; it is informational only.

What is the Meyka AI forecast for PRFN.SW stock?

Meyka AI's forecast model projects **CHF 0.065** for PRFN.SW, an implied upside of **80.56%** versus **CHF 0.036**. Forecasts are model-based projections and not guarantees.

What are the main risks for PRFN.SW stock?

Key risks include trial or development setbacks, funding dilution, low liquidity and wide spreads. Microcap status can cause amplified moves on sparse news or block trades.

CH Stocks

PRFN.SW Kinarus Therapeutics (SIX) 29 Jan 2026: CHF 0.036 intraday on heavy volume, watch resistance

ByHuzaifa Zahoor January 29, 2026

PRFN.SW stock trades intraday at CHF 0.036 on 29 Jan 2026 after a one-day drop of -8.12% and a surge in volume to 2,937,350 shares. Kinarus Therapeutics Holding AG (PRFN.SW) is listed on the SIX in Switzerland and shows wide intraday range, low liquidity but elevated activity relative to its 50-day average volume. The stock sits well below its 50-day average price of CHF 0.073 and 200-day average of CHF 0.074, raising near-term technical resistance while fundamental metrics point to continued development-stage risk.